US 2026/0060943 A1Published application

Ovarian cancer vaccines

AssigneeThe Cleveland Clinic Foundation

InventorsVincent K. TUOHY, Suparna MAZUMDER, Justin M. JOHNSON

Life of this patent

Estimating the term…

Abstract

Provided herein are methods, kits and compositions for the treatment and/or prevention of ovarian cancer through the induction of an immune response against Anti-Mullerian Hormone Receptor, Type II (AMHR2).

Claims21

Dependent claims

1-83. (canceled)

Dependencies are inferred from the claim text.

Facts

Application: 19/268,344Filed 14 Jul 2025
Priority: 2 Sep 2015
Published: 5 Mar 2026
Term ends: Not estimatedThe source records don’t support an estimate.

Classification25 codes

A61K 31/138
Having aromatic rings , e.g. ketamine, nortriptyline: aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
A61K 31/337
Having oxygen as the only ring hetero atom, e.g. fungichromin: having four-membered rings, e.g. taxol
A61K 31/4196
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: 1,2,4-Triazoles
A61K 31/4745
Ortho- or peri-condensed with heterocyclic ring systems: condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines

Family

Application62/213,286Us provisional application · filed 2 Sep 2015
Application17/404,025Continuation · filed 17 Aug 2021
Application18/462,648Continuation · filed 7 Sep 2023
Application19/268,344Continuation
Application15/757,151Continuation
US 11,090,284 B2Related patent
US 11,786,489 B2Related patent
US 12,357,593 B2Related patent
US 2019/0134173 A1Published application
US 2021/0379171 A1Published application
US 2024/0041798 A1Published application
US 2026/0060943 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results